InsiderClue
Stocks · Health care · Biological Products, (No Diagnostic Substances)

Moderna

MRNA Clue Score25
United States Fiscal year ends December CIK 0001682852 Results filed 31 Jul 2026
Add to watchlist

What the insiders did Net selling

Individual transactions

20
Insider
Date
Role
Action
Shares
Price
Amount
Stephen Hoge
15 Oct 2026
President
Sold after exercise
39,145
$220.72
$8.64M
Stephen Hoge
14 Oct 2026
President
Sold after exercise
450
$214.15
$96.37K
Stephen Hoge
14 Oct 2026
President
Sold after exercise
38,774
$213.47
$8.28M
Stephen Hoge
15 Sep 2026
President
Sold after exercise
40,281
$146.07
$5.88M
Stephen Hoge
14 Sep 2026
President
Sold after exercise
40,294
$144.13
$5.81M
James M Mock
10 Sep 2026
Chief Financial Officer
Sold after exercise
15,000
$134.49
$2.02M
James M Mock
10 Sep 2026
Chief Financial Officer
Sold after exercise
19,836
$134.49
$2.67M
Shannon Thyme Klinger
1 Sep 2026
Chief Legal Officer
Sold after exercise
3,471
$139.95
$485.77K
Stephane Bancel
5 Aug 2026
Chief Executive Officer
Sold after exercise
187,044
$58.79
$11.00M
Stephane Bancel
5 Aug 2026
Chief Executive Officer
Sold after exercise
39,891
$58.12
$2.32M
Stephane Bancel
5 Aug 2026
Chief Executive Officer
Sold after exercise
124,838
$56.96
$7.11M
Stephane Bancel
5 Aug 2026
Chief Executive Officer
Sold after exercise
147,473
$56.21
$8.29M
Stephen Hoge
15 Jul 2026
President
Sold after exercise
53,336
$67.60
$3.61M
Stephen Hoge
15 Jun 2026
President
Sold after exercise
53,336
$51.37
$2.74M
Shannon Thyme Klinger
4 Jun 2026
Chief Legal Officer
Sold after exercise
3,471
$50.00
$173.55K
Noubar Afeyan
21 May 2026
Director
Sold after exercise indirect
9,263
$46.84
$433.88K
Stephen Hoge
15 May 2026
President
Sold after exercise
53,336
$48.40
$2.58M
Shannon Thyme Klinger
2 Mar 2026
Chief Legal Officer
Sold after exercise
13,885
$52.29
$726.05K
Stephen Hoge
23 Feb 2026
President
Sold after exercise
160,009
$48.84
$7.81M
Noubar Afeyan
11 Dec 2025
Director
Sold after exercise indirect
23,853
$29.49
$703.31K
Showing 250 of 2,806 transactions. The figures above use every one of them.

What was left out

Form 4 filings counted 1,018
Amendments (4/A) skipped 12
Filings about a different issuer 0
Unreadable filings 0
Joint filings 5
Sales on a Rule 10b5-1 plan 279
Sales straight out of an exercise 1,515
Sales at will 998
Transactions with no price 1
Shares from compensation/vesting 108,736,664
Sales filed before the plan box existed 994
History held since 13 Dec 2018